MARC D KOZIN
CIK 1241647 · last filed 2026-06-08
MARC D KOZIN is a corporate insider who has filed 86 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for UFPT, was dated Jun 8, 2026. Across all open-market trades the lifetime net is −$753.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$9.14M
9
86
-$753.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UFPT | Director | 28,112 | $325.00 | $9.14M | -$1.12M | 34 | 2026-06-08 |
| CHIMERIX INC (CMRX) Delisted | Director | — | $8.54 | — | $0 | 3 | 2025-04-21 |
| Dicerna Pharmaceuticals Inc (DRNA) Delisted | Director | 0 | $38.22 | $0 | $71.0K | 6 | 2021-12-29 |
| Isleworth Healthcare Acquisition Corp. (ISLEW) Delisted | Director | 0 | $0.00 | $0 | $0 | 1 | 2021-09-10 |
| ENDOCYTE INC (ECYT) Delisted | Director | 0 | — | — | $0 | 7 | 2018-12-21 |
| Tempest Therapeutics, Inc. (MLND) Delisted | Director | 516 | $15.90 | $8.2K | $0 | 1 | 2018-12-11 |
| Tempest Therapeutics, Inc. (OVAS) Delisted | Director | 6,910 | — | — | $189.9K | 23 | 2018-10-02 |
| Salarius Pharmaceuticals, Inc. (FLKS) Delisted | Director | 180 | — | — | $51.2K | 5 | 2018-07-26 |
| DYAX CORP (DYAX) Delisted | Director | 0 | — | — | $56.6K | 6 | 2016-01-22 |
Recent Filings
86 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-08 | UFPT | Grant (A) | +802 | $0 | EDGAR |
| 2025-06-06 | UFPT | Grant (A) | +625 | $0 | EDGAR |
| 2025-04-21 | CHIMERIX INC (CMRX) Delisted | Disp (D) | — | $0 | EDGAR |
| 2024-10-03 | UFPT | Gift (G) | −1,500 | $0 | EDGAR |
| 2024-06-21 | CHIMERIX INC (CMRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | UFPT | Grant (A) | +230 | $0 | EDGAR |
| 2024-03-21 | CHIMERIX INC (CMRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-08 | UFPT | Grant (A) | +298 | $0 | EDGAR |
| 2023-03-10 | UFPT | Gift (G) | −1,000 | $0 | EDGAR |
| 2022-06-10 | UFPT | Grant (A) | +647 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.